1. Alan Agresti . 1992. A survey of exact inference for contingency tables. Statistical science 7, 1 ( 1992 ), 131–153. Alan Agresti. 1992. A survey of exact inference for contingency tables. Statistical science 7, 1 (1992), 131–153.
2. John Arrowsmith and Philip Miller . 2013. Trial watch: phase II and phase III attrition rates 2011-2012. Nature reviews. Drug discovery 12, 8 ( 2013 ), 569. John Arrowsmith and Philip Miller. 2013. Trial watch: phase II and phase III attrition rates 2011-2012. Nature reviews. Drug discovery 12, 8 (2013), 569.
3. Juan M Banda , Lee Evans , Rami S Vanguri , Nicholas P Tatonetti , Patrick B Ryan , and Nigam H Shah . 2016. A curated and standardized adverse drug event resource to accelerate drug safety research. Scientific data 3, 1 ( 2016 ), 1–11. Juan M Banda, Lee Evans, Rami S Vanguri, Nicholas P Tatonetti, Patrick B Ryan, and Nigam H Shah. 2016. A curated and standardized adverse drug event resource to accelerate drug safety research. Scientific data 3, 1 (2016), 1–11.
4. Bio2RDF: Towards a mashup to build bioinformatics knowledge systems
5. Aurel Cami , Alana Arnold , Shannon Manzi , and Ben Reis . 2011. Predicting adverse drug events using pharmacological network models. Science translational medicine 3, 114 ( 2011 ), 114ra127–114ra127. Aurel Cami, Alana Arnold, Shannon Manzi, and Ben Reis. 2011. Predicting adverse drug events using pharmacological network models. Science translational medicine 3, 114 (2011), 114ra127–114ra127.